Nature and management of melanoma recurrences following adjuvant anti-PD-1 based therapy.

Woodford R, McKeown J, Hoeijmakers LL, Mangana J, Dimitriou F, Allayous C, Zaman F, Aya F, Marsiglio J, Goodman R, Rayson V, Placzke J, Kessels J, Ramalyte E, Haque W, Wilson I, Trojaniello C, Benannoune N, Roberts-Thomson R, Robert C, Blank CU, Dummer R, Lebbe C, Haydon A, Arance A, Hu-Lieskovan S, Johnson DB, Mcarthur GA, Rutkowski P, Neyns B, Sullivan RJ, Weber J, Carlino MS, Ascierto PA, Lo S, Long GV, Menzies AM

Open source

DOI: 10.1016/j.ejca.2024.115055
Published: 2024 Nov
Container: European journal of cancer (Oxford, England : 1990)
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ejca.2024.115055,
  title = {Nature and management of melanoma recurrences following adjuvant anti-PD-1 based therapy.},
  author = {Woodford R and McKeown J and Hoeijmakers LL and Mangana J and Dimitriou F and Allayous C and Zaman F and Aya F and Marsiglio J and Goodman R and Rayson V and Placzke J and Kessels J and Ramalyte E and Haque W and Wilson I and Trojaniello C and Benannoune N and Roberts-Thomson R and Robert C and Blank CU and Dummer R and Lebbe C and Haydon A and Arance A and Hu-Lieskovan S and Johnson DB and Mcarthur GA and Rutkowski P and Neyns B and Sullivan RJ and Weber J and Carlino MS and Ascierto PA and Lo S and Long GV and Menzies AM},
  year = {2024},
  journal = {European journal of cancer (Oxford, England : 1990)},
  doi = {10.1016/j.ejca.2024.115055},
  url = {https://doi.org/10.1016/j.ejca.2024.115055}
}

RIS

TY  - JOUR
TI  - Nature and management of melanoma recurrences following adjuvant anti-PD-1 based therapy.
AU  - Woodford R
AU  - McKeown J
AU  - Hoeijmakers LL
AU  - Mangana J
AU  - Dimitriou F
AU  - Allayous C
AU  - Zaman F
AU  - Aya F
AU  - Marsiglio J
AU  - Goodman R
AU  - Rayson V
AU  - Placzke J
AU  - Kessels J
AU  - Ramalyte E
AU  - Haque W
AU  - Wilson I
AU  - Trojaniello C
AU  - Benannoune N
AU  - Roberts-Thomson R
AU  - Robert C
AU  - Blank CU
AU  - Dummer R
AU  - Lebbe C
AU  - Haydon A
AU  - Arance A
AU  - Hu-Lieskovan S
AU  - Johnson DB
AU  - Mcarthur GA
AU  - Rutkowski P
AU  - Neyns B
AU  - Sullivan RJ
AU  - Weber J
AU  - Carlino MS
AU  - Ascierto PA
AU  - Lo S
AU  - Long GV
AU  - Menzies AM
PY  - 2024
JO  - European journal of cancer (Oxford, England : 1990)
DO  - 10.1016/j.ejca.2024.115055
UR  - https://doi.org/10.1016/j.ejca.2024.115055
ER  -

APA

R, W., J, M., LL, H., J, M., F, D., C, A., F, Z., F, A., J, M., R, G., V, R., J, P., J, K., E, R., W, H., I, W., C, T., N, B., R, R., C, R., CU, B., R, D., C, L., A, H., A, A., S, H., DB, J., GA, M., P, R., B, N., RJ, S., J, W., MS, C., PA, A., S, L., GV, L., & AM, M. (2024). Nature and management of melanoma recurrences following adjuvant anti-PD-1 based therapy.. European journal of cancer (Oxford, England : 1990). https://doi.org/10.1016/j.ejca.2024.115055

Source records

pubmed · retrieved 2026-09-26T03:39:19.237Z